{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:01:01Z","timestamp":1793325661418,"version":"4.5.0"},"reference-count":159,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"DOI":"10.1186\/s13643-024-02700-3","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T03:53:08Z","timestamp":1734580388000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Screening for breast\u00a0cancer: a systematic review update to inform the Canadian Task Force on Preventive Health Care guideline"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5977-2094","authenticated-orcid":false,"given":"Alexandria","family":"Bennett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Shaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niyati","family":"Vyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faris","family":"Almoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Pap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taddele","family":"Kibret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Becky","family":"Skidmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Yaffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean M.","family":"Seely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Little","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Moher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,19]]},"reference":[{"key":"2700_CR1","unstructured":"Canadian Cancer Society \/ Soci\u00e9t\u00e9 canadienne du. Breast cancer statistics [Internet]. Canadian Cancer Society. 2023 [cited 2024 Mar 21]. Available from: https:\/\/cancer.ca\/en\/cancer-information\/cancer-types\/breast\/statistics"},{"key":"2700_CR2","doi-asserted-by":"crossref","unstructured":"Brenner DR, Poirier A, Woods RR, Ellison LF, Billette JM, Demers AA, et al. Projected estimates of cancer in Canada in 2022. CMAJ [Internet]. 2022 May 2 [cited 2024 Jan 14];194(17):E601\u20137. Available from: https:\/\/www.cmaj.ca\/content\/194\/17\/e601","DOI":"10.1503\/cmaj.212097"},{"issue":"9","key":"2700_CR3","doi-asserted-by":"publisher","first-page":"635","DOI":"10.7326\/0003-4819-156-9-201205010-00006","volume":"156","author":"HD Nelson","year":"2012","unstructured":"Nelson HD, Zakher B, Cantor A, Fu R, Griffin J, O\u2019Meara ES, et al. Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med. 2012May 1;156(9):635\u201348.","journal-title":"Ann Intern Med"},{"issue":"6","key":"2700_CR4","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1001\/jamasurg.2018.0035","volume":"153","author":"SM Stapleton","year":"2018","unstructured":"Stapleton SM, Oseni TO, Bababekov YJ, Hung YC, Chang DC. Race\/ethnicity and age distribution of breast cancer diagnosis in the United States. JAMA Surg. 2018;153(6):594\u20135.","journal-title":"JAMA Surg"},{"issue":"4","key":"2700_CR5","first-page":"725","volume":"101","author":"CI Lee","year":"2017","unstructured":"Lee CI, Chen LE, Elmore JG. Risk-based breast cancer screening: implications of breast density. Medical Clinics. 2017;101(4):725\u201341.","journal-title":"Medical Clinics"},{"issue":"3","key":"2700_CR6","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1056\/NEJMoa062790","volume":"356","author":"NF Boyd","year":"2007","unstructured":"Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med. 2007Jan 18;356(3):227\u201336.","journal-title":"N Engl J Med"},{"issue":"24","key":"2700_CR7","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1056\/NEJMsr1504363","volume":"372","author":"L-S B\u00e9atrice","year":"2015","unstructured":"B\u00e9atrice L-S, Chiara S, Dana L, Lamia B-T, V\u00e9ronique B, Franca B, et al. Breast-cancer screening\u2014viewpoint of the IARC Working Group. N Engl J Med. 2015;372(24):2353\u20138.","journal-title":"N Engl J Med"},{"issue":"9310","key":"2700_CR8","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/S0140-6736(02)08020-0","volume":"359","author":"L Nystr\u00f6m","year":"2002","unstructured":"Nystr\u00f6m L, Andersson I, Bjurstam N, Frisell J, Nordenskj\u00f6ld B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. The Lancet. 2002;359(9310):909\u201319.","journal-title":"The Lancet"},{"issue":"1","key":"2700_CR9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1177\/0969141316648987","volume":"24","author":"L Nystr\u00f6m","year":"2017","unstructured":"Nystr\u00f6m L, Bjurstam N, Jonsson H, Zackrisson S, Frisell J. Reduced breast cancer mortality after 20+ years of follow-up in the Swedish randomized controlled mammography trials in Malm\u00f6, Stockholm, and G\u00f6teborg. J Med Screen. 2017Mar;24(1):34\u201342.","journal-title":"J Med Screen"},{"key":"2700_CR10","doi-asserted-by":"crossref","unstructured":"Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ. 2014 Feb 11;348(feb11 9):g366\u2013g366.","DOI":"10.1136\/bmj.g366"},{"key":"2700_CR11","doi-asserted-by":"crossref","unstructured":"Seely JM, Alhassan T. Screening for breast cancer in 2018\u2014what should we be doing today? Curr Oncol [Internet]. 2018 Jun [cited 2024 Jan 14];25(Suppl 1):S115\u201324. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6001765\/","DOI":"10.3747\/co.25.3770"},{"key":"2700_CR12","unstructured":"IARC Working Group on the Evaluation of Cancer-Preventive. Breast Cancer Screening. IARC Handbooks of Cancer Prevention, Volume 15. 2016;"},{"key":"2700_CR13","doi-asserted-by":"crossref","unstructured":"Nelson HD, Fu R, Cantor A, Pappas M, Daeges M, Humphrey L. Effectiveness of breast cancer screening: systematic review and meta-analysis to update the 2009 U.S. Preventive Services Task Force Recommendation. 2016;164(4).","DOI":"10.7326\/M15-0969"},{"issue":"10","key":"2700_CR14","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1002\/pon.1676","volume":"19","author":"T Salz","year":"2010","unstructured":"Salz T, Richman AR, Brewer NT. Meta-analyses of the effect of false-positive mammograms on generic and specific psychosocial outcomes. Psychooncology. 2010Oct;19(10):1026\u201334.","journal-title":"Psychooncology"},{"key":"2700_CR15","doi-asserted-by":"crossref","unstructured":"Srivastava S, Koay EJ, Borowsky AD, De Marzo AM, Ghosh S, Wagner PD, et al. Cancer overdiagnosis: a biological challenge and clinical dilemma. Nat Rev Cancer [Internet]. 2019 Jun [cited 2024 Jan 14];19(6):349\u201358. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8819710\/","DOI":"10.1038\/s41568-019-0142-8"},{"issue":"2","key":"2700_CR16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/clc.22631","volume":"40","author":"P Sardar","year":"2017","unstructured":"Sardar P, Kundu A, Chatterjee S, Nohria A, Nairooz R, Bangalore S, et al. Long-term cardiovascular mortality after radiotherapy for breast cancer: a systematic review and meta-analysis. Clin Cardiol. 2017Feb;40(2):73\u201381.","journal-title":"Clin Cardiol"},{"key":"2700_CR17","unstructured":"Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years. CMAJ. 1992 Nov 15;147(10):1477\u201388."},{"issue":"2","key":"2700_CR18","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1093\/jbi\/wbab099","volume":"4","author":"JM Seely","year":"2022","unstructured":"Seely JM, Eby PR, Yaffe MJ. The fundamental flaws of the CNBSS Trials: a scientific review. Journal of Breast Imaging. 2022Mar 1;4(2):108\u201319.","journal-title":"Journal of Breast Imaging"},{"issue":"1","key":"2700_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/09691413211059461","volume":"29","author":"MJ Yaffe","year":"2022","unstructured":"Yaffe MJ, Seely JM, Gordon PB, Appavoo S, Kopans DB. The randomized trial of mammography screening that was not\u2014a cautionary tale. J Med Screen. 2022Mar;29(1):7\u201311.","journal-title":"J Med Screen"},{"key":"2700_CR20","doi-asserted-by":"crossref","unstructured":"Duffy SW. Problems with the Canadian national breast screening studies [Internet]. Vol. 4, Journal of Breast Imaging. Oxford University Press US; 2022 [cited 2024 Apr 2]. p. 120\u20131. Available from: https:\/\/academic.oup.com\/jbi\/article-abstract\/4\/2\/120\/6555325","DOI":"10.1093\/jbi\/wbac004"},{"issue":"2","key":"2700_CR21","first-page":"207","volume":"156","author":"NF Boyd","year":"1997","unstructured":"Boyd NF. The review of randomization in the Canadian National Breast Screening Study: is the debate over? CMAJ. 1997Jan 15;156(2):207\u20139.","journal-title":"CMAJ"},{"key":"2700_CR22","doi-asserted-by":"crossref","unstructured":"Kopans DB. The Canadian National Breast Screening Studies are compromised and their results are unreliable. They should not factor into decisions about breast cancer screening. Breast Cancer Res Treat. 2017 Aug 1;165(1):9\u201315.","DOI":"10.1007\/s10549-017-4302-9"},{"key":"2700_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.622621","volume":"11","author":"S Keelan","year":"2021","unstructured":"Keelan S, Flanagan M, Hill ADK. Evolving trends in surgical management of breast cancer: an analysis of 30 years of practice changing papers. Front Oncol. 2021;11: 622621.","journal-title":"Front Oncol"},{"issue":"21","key":"2700_CR24","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1200\/JCO.20.00199","volume":"38","author":"GN Hortobagyi","year":"2020","unstructured":"Hortobagyi GN. Breast Cancer: 45 Years of research and progress. JCO. 2020Jul 20;38(21):2454\u201362.","journal-title":"JCO"},{"issue":"30","key":"2700_CR25","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1200\/JCO.2018.78.0270","volume":"36","author":"AB Beau","year":"2018","unstructured":"Beau AB, Andersen PK, Vejborg I, Lynge E. Limitations in the effect of screening on breast cancer mortality. JCO. 2018Oct 20;36(30):2988\u201394.","journal-title":"JCO"},{"issue":"49","key":"2700_CR26","doi-asserted-by":"publisher","first-page":"E1441","DOI":"10.1503\/cmaj.180463","volume":"190","author":"S Klarenbach","year":"2018","unstructured":"Klarenbach S, Sims-Jones N, Lewin G, Singh H, Th\u00e9riault G, Tonelli M, et al. Recommendations on screening for breast cancer in women aged 40\u201374 years who are not at increased risk for breast cancer. CMAJ. 2018Dec 10;190(49):E1441\u201351.","journal-title":"CMAJ"},{"key":"2700_CR27","unstructured":"My breast screening. [cited 2024 Apr 24]. Available from: https:\/\/mybreastscreening.ca\/about\/"},{"key":"2700_CR28","unstructured":"U.S. Preventive Services Task Force. Draft Recommendation: Breast Cancer: Screening | United States Preventive Services Taskforce [Internet]. 2023 [cited 2023 Jun 22]. Available from: https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/draft-recommendation\/breast-cancer-screening-adults"},{"issue":"11","key":"2700_CR29","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1038\/bjc.2013.177","volume":"108","author":"MG Marmot","year":"2013","unstructured":"Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M. The benefits and harms of breast cancer screening: an independent review. Br J Cancer. 2013Jun 11;108(11):2205\u201340.","journal-title":"Br J Cancer"},{"key":"2700_CR30","unstructured":"Cancer Registry of Norway. BreastScreen Norway [Internet]. 2023 [cited 2024 Apr 2]. Available from: https:\/\/www.kreftregisteret.no\/en\/screening\/BreastScreen_Norway\/breastscreen-norway\/"},{"key":"2700_CR31","unstructured":"Finish Cancer Registry. Breast cancer screening [Internet]. Sy\u00f6p\u00e4rekisteri. 2023 [cited 2024 Apr 2]. Available from: https:\/\/cancerregistry.fi\/screening\/breast-cancer-screening\/"},{"key":"2700_CR32","unstructured":"Danish Cancer Society. Kr\u00e6ftens Bek\u00e6mpelse [Internet]. 2024 [cited 2024 Apr 2]. Available from: https:\/\/www.cancer.dk\/forebyg-kraeft\/screening\/brystkraeft\/in-other-languages\/"},{"issue":"5","key":"2700_CR33","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1159\/000321255","volume":"5","author":"H Lind","year":"2010","unstructured":"Lind H, Svane G, Kemetli L, T\u00f6rnberg S. Breast cancer screening program in Stockholm County, Sweden\u2014aspects of organization and quality assurance. Breast Care (Basel). 2010Oct;5(5):353\u20137.","journal-title":"Breast Care (Basel)"},{"key":"2700_CR34","unstructured":"Ottawa Knowledge Synthesis Group. Breast cancer screening: Part A. An evidence report to inform an update of the Canadian Task Force on Preventive Health Care 2011 Guideline [Internet]. 2018 [cited 2023 Jun 22]. Available from: https:\/\/canadiantaskforce.ca\/wp-content\/uploads\/2019\/02\/Systematic-Review-Evidence-Report_v2_FINAL.pdf"},{"key":"2700_CR35","unstructured":"Higgins J, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0. [Internet] http:\/\/handbook.cochrane.org\/. 2011."},{"key":"2700_CR36","unstructured":"GRADE Working Group. Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach. 2013 Oct; Available from: https:\/\/gdt.gradepro.org\/app\/handbook\/handbook.html"},{"key":"2700_CR37","unstructured":"Canadian Task Force on Preventive Health Care. Canadian Task Force on Preventive Health Care Procedure Manual [Internet]. 2014. Available from: https:\/\/canadiantaskforce.ca\/wp-content\/uploads\/2016\/12\/procedural-manual-en_2014_Archived.pdf"},{"key":"2700_CR38","first-page":"372","volume":"2021","author":"MJ Page","year":"2020","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, The PRISMA, et al. statement: an updated guideline for reporting systematic reviews. BMJ. 2020;2021:372.","journal-title":"BMJ"},{"key":"2700_CR39","unstructured":"Government of Canada CI of HR. Patient partner compensation guidelines - CIHR [Internet]. 2022 [cited 2024 Feb 23]. Available from: https:\/\/cihr-irsc.gc.ca\/e\/53261.html"},{"key":"2700_CR40","unstructured":"Riva JJ, Malik KMP, Burnie SJ, Endicott AR, Busse JW. Commentary what is your research question? An introduction to the PICOT format for clinicians."},{"key":"2700_CR41","unstructured":"Breast and ovarian cancer and family history risk categories | CDC [Internet]. 2023 [cited 2023 Jul 18]. Available from: https:\/\/www.cdc.gov\/genomics\/disease\/breast_ovarian_cancer\/risk_categories.htm"},{"key":"2700_CR42","doi-asserted-by":"crossref","unstructured":"Klarenbach S, Sims-Jones N, Lewin G, Singh H, Th\u00e9riault G, Tonelli M, et al. Recommendations on screening for breast cancer in women aged 40\u201374 years who are not at increased risk for breast cancer. CMAJ [Internet]. 2018 Dec 10 [cited 2024 Jan 14];190(49):E1441\u201351. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6279444\/","DOI":"10.1503\/cmaj.180463"},{"key":"2700_CR43","doi-asserted-by":"crossref","unstructured":"Siu AL, on behalf of the U.S. Preventive services task force. Screening for depression in children and adolescents: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2016;164(5):360.","DOI":"10.7326\/M15-2957"},{"key":"2700_CR44","unstructured":"Evidence Partners. DistillerSR [Internet]. Ottawa, Canada. https:\/\/www.evidencepartners.com\/; 2011. Available from: https:\/\/www.evidencepartners.com\/"},{"issue":"366","key":"2700_CR45","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","volume":"28","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019Aug;28(366): l4898.","journal-title":"BMJ"},{"key":"2700_CR46","unstructured":"Joanna Briggs Institute. The Joanna Briggs Institute Critical Appraisal tools for use in JBI Systematic Reviews Checklist for Prevalence Studies [Internet]. Joanna Briggs Institute. 2017. Available from: https:\/\/jbi.global\/sites\/default\/files\/2019-05\/JBI_Critical_Appraisal-Checklist_for_Prevalence_Studies2017_0.pdf"},{"key":"2700_CR47","doi-asserted-by":"crossref","unstructured":"The Independent UK Panel on Breast Cancer Screening, Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, et al. The benefits and harms of breast cancer screening: an independent review: a report jointly commissioned by Cancer Research UK and the Department of Health (England) October 2012. Br J Cancer. 2013 Jun;108(11):2205\u201340.","DOI":"10.1038\/bjc.2013.177"},{"key":"2700_CR48","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jclinepi.2019.10.015","volume":"118","author":"N Skoetz","year":"2020","unstructured":"Skoetz N, Goldkuhle M, van Dalen EC, Akl EA, Trivella M, Mustafa RA, et al. GRADE guidelines 27: how to calculate absolute effects for time-to-event outcomes in summary of findings tables and Evidence Profiles. J Clin Epidemiol. 2020Feb;118:124\u201331.","journal-title":"J Clin Epidemiol"},{"key":"2700_CR49","doi-asserted-by":"crossref","unstructured":"Coldman A, Phillips N, Wilson C, Decker K, Chiarelli AM, Brisson J, et al. Pan-Canadian study of mammography screening and mortality from breast cancer. 2014;106(11).","DOI":"10.1093\/jnci\/dju261"},{"key":"2700_CR50","unstructured":"Deeks JJ, Higgins JPT, Altman DG. Chapter 10: Analysing data and undertaking meta-analyses. In: Cochrane Handbook for Systematic Reviews of Interventions version 62 (updated February 2021) [Internet]. 2021 [cited 2021 Mar 9]. Available from: https:\/\/training.cochrane.org\/handbook\/current\/chapter-10"},{"key":"2700_CR51","unstructured":"R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. [Internet]. 2021. Available from: https:\/\/www.R-project.org\/"},{"issue":"3","key":"2700_CR52","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177\u201388.","journal-title":"Control Clin Trials"},{"key":"2700_CR53","unstructured":"McKenzie JE, Brennan SE. Chapter 12: Synthesizing and presenting findings using other methods. In: Cochrane Handbook for Systematic Reviews of Interventions. 2023."},{"key":"2700_CR54","unstructured":"Canadian Partnership Against Cancer (CPAC). Breast Cancer Screening in Canada: monitoring and evaluation of quality indicators\u2014results report, January 2011 to December 2012. Toronto, ON: Canadian Partnership Against Cancer; 2016."},{"key":"2700_CR55","unstructured":"Nova Scotia Breast Screening Program. Imaging Guidelines [Internet]. Nova Scotia Breast Cancer Screening Program. Available from: https:\/\/nsbreastscreening.ca\/program-information\/imaging-guidelines"},{"key":"2700_CR56","unstructured":"Health PEI. PEI Breast Screening Program [Internet]. Government of Prince Edward Island. 2023. Available from: https:\/\/www.princeedwardisland.ca\/en\/information\/health-pei\/pei-breast-screening-program"},{"issue":"1","key":"2700_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/ebmed-2017-110886","volume":"23","author":"J Brodersen","year":"2018","unstructured":"Brodersen J, Schwartz LM, Heneghan C, O\u2019Sullivan JW, Aronson JK, Woloshin S. Overdiagnosis: what it is and what it isn\u2019t. BMJ EBM. 2018;23(1):1\u20133.","journal-title":"BMJ EBM"},{"issue":"12","key":"2700_CR58","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/S1470-2045(07)70380-7","volume":"8","author":"C Biesheuvel","year":"2007","unstructured":"Biesheuvel C, Barratt A, Howard K, Houssami N, Irwig L. Effects of study methods and biases on estimates of invasive breast cancer overdetection with mammography screening: a systematic review. Lancet Oncol. 2007;8(12):1129\u201338.","journal-title":"Lancet Oncol"},{"key":"2700_CR59","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ejca.2016.12.030","volume":"75","author":"D Puliti","year":"2017","unstructured":"Puliti D, Bucchi L, Mancini S, Paci E, Baracco S, Campari C, et al. Advanced breast cancer rates in the epoch of service screening: the 400,000 women cohort study from Italy. Eur J Cancer. 2017Apr;75:109\u201316.","journal-title":"Eur J Cancer"},{"key":"2700_CR60","doi-asserted-by":"crossref","unstructured":"Carter JL, Coletti RJ, Harris RP. Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods. BMJ. 2015 Jan 7;350(jan07 5):g7773\u2013g7773.","DOI":"10.1136\/bmj.g7773"},{"key":"2700_CR61","doi-asserted-by":"publisher","unstructured":"Ripping TM, ten Haaf K, Verbeek ALM, van Ravesteyn NT, Broeders MJM. Quantifying overdiagnosis in cancer screening: a systematic review to evaluate the methodology. JNCI: Journal of the National Cancer Institute [Internet]. 2017 Oct 1 [cited 2024 Apr 3];109(10). Available from: https:\/\/academic.oup.com\/jnci\/article\/doi\/https:\/\/doi.org\/10.1093\/jnci\/djx060\/3845953","DOI":"10.1093\/jnci\/djx060\/3845953"},{"issue":"7109","key":"2700_CR62","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997Sep;315(7109):629\u201334.","journal-title":"BMJ"},{"key":"2700_CR63","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jclinepi.2022.07.014","volume":"150","author":"L Zeng","year":"2022","unstructured":"Zeng L, Brignardello-Petersen R, Hultcrantz M, Mustafa RA, Murad MH, Iorio A, et al. GRADE Guidance 34: update on rating imprecision using a minimally contextualized approach. J Clin Epidemiol. 2022Oct;150:216\u201324.","journal-title":"J Clin Epidemiol"},{"key":"2700_CR64","unstructured":"Sch\u00fcnemann HJ, Higgins JP, Vist GE, Glasziou P, Akl EA, Skoetz N, et al. Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence. In: Cochrane Handbook for Systematic Reviews of Interventions [Internet]. 2023. Available from: https:\/\/training.cochrane.org\/handbook\/current\/chapter-14"},{"key":"2700_CR65","doi-asserted-by":"crossref","unstructured":"Guyatt GH, Oxman AD, Sultan S, Glasziou P, Akl EA, Alonso-Coello P, et al. GRADE guidelines: 9. Rating up the quality of evidence. J Clin Epidemiol. 2011 Dec;64(12):1311\u20136.","DOI":"10.1016\/j.jclinepi.2011.06.004"},{"issue":"9","key":"2700_CR66","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1001\/jamaoncol.2016.6326","volume":"3","author":"NJ Engmann","year":"2017","unstructured":"Engmann NJ, Golmakani MK, Miglioretti DL, Sprague BL, Kerlikowske K. Population-attributable risk proportion of clinical risk factors for breast cancer. JAMA Oncol. 2017Sep 1;3(9):1228\u201336.","journal-title":"JAMA Oncol"},{"issue":"5","key":"2700_CR67","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1158\/1055-9965.EPI-09-1028","volume":"19","author":"SYH Chiu","year":"2010","unstructured":"Chiu SYH, Duffy S, Yen AMF, Tab\u00e1r L, Smith RA, Chen HH. Effect of baseline breast density on breast cancer incidence, stage, mortality, and screening parameters: 25-year follow-up of a Swedish mammographic screening. Cancer Epidemiol Biomark Prev. 2010May 1;19(5):1219\u201328.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"1","key":"2700_CR68","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/ijc.30430","volume":"140","author":"D van der Waal","year":"2017","unstructured":"van der Waal D, Ripping TM, Verbeek ALM, Broeders MJM. Breast cancer screening effect across breast density strata: a case-control study: Screening effect across breast density strata. Int J Cancer. 2017Jan 1;140(1):41\u20139.","journal-title":"Int J Cancer"},{"issue":"9","key":"2700_CR69","first-page":"14","volume":"34","author":"JL Liu","year":"2023","unstructured":"Liu JL, Zhang SX, Billette JM, Demers AA. Lifetime probability of developing cancer and dying from cancer in Canada, 1997 to 2020. Health Rep. 2023Sep 20;34(9):14\u201321.","journal-title":"Health Rep"},{"issue":"9","key":"2700_CR70","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/S1470-2045(20)30398-3","volume":"21","author":"SW Duffy","year":"2020","unstructured":"Duffy SW, Vulkan D, Cuckle H, Parmar D, Sheikh S, Smith RA, et al. Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial. Lancet Oncol. 2020Sep;21(9):1165\u201372.","journal-title":"Lancet Oncol"},{"issue":"55","key":"2700_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta24550","volume":"24","author":"S Duffy","year":"2020","unstructured":"Duffy S, Vulkan D, Cuckle H, Parmar D, Sheikh S, Smith R, et al. Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT. Health Technol Assess. 2020Oct;24(55):1\u201324.","journal-title":"Health Technol Assess"},{"issue":"4","key":"2700_CR72","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1002\/1097-0142(19950215)75:4<997::AID-CNCR2820750415>3.0.CO;2-M","volume":"75","author":"RE Tarone","year":"1995","unstructured":"Tarone RE. The excess of patients with advanced breast cancer in young women screened with mammography in the Canadian National Breast Screening Study. Cancer. 1995;75(4):997\u20131003.","journal-title":"Cancer"},{"issue":"1","key":"2700_CR73","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41523-021-00295-9","volume":"7","author":"E Choi","year":"2021","unstructured":"Choi E, Jun JK, Suh M, Jung KW, Park B, Lee K, et al. Effectiveness of the Korean National Cancer Screening Program in reducing breast cancer mortality. NPJ breast cancer. 2021;7(1):83.","journal-title":"NPJ breast cancer"},{"issue":"3","key":"2700_CR74","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1148\/radiol.2021203935","volume":"299","author":"SW Duffy","year":"2021","unstructured":"Duffy SW, Tabar L, Yen AMF, Dean PB, Smith RA, Jonsson H, et al. Beneficial effect of consecutive screening mammography examinations on mortality from breast cancer: a prospective study. Radiology. 2021;299(3):541\u20137.","journal-title":"Radiology"},{"issue":"2","key":"2700_CR75","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1177\/0969141320950776","volume":"28","author":"N Dunn","year":"2021","unstructured":"Dunn N, Youl P, Moore J, Harden H, Walpole E, Evans E, et al. Breast-cancer mortality in screened versus unscreened women: long-term results from a population-based study in Queensland. Australia Journal of medical screening. 2021;28(2):193\u20139.","journal-title":"Australia Journal of medical screening"},{"issue":"6","key":"2700_CR76","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/bjc.2017.6","volume":"116","author":"S Morrell","year":"2017","unstructured":"Morrell S, Taylor R, Roder D, Robson B, Gregory M, Craig K. Mammography service screening and breast cancer mortality in New Zealand: a national cohort study 1999\u20132011. Br J Cancer. 2017Mar;116(6):828\u201339.","journal-title":"Br J Cancer"},{"key":"2700_CR77","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ejca.2017.11.003","volume":"89","author":"E Lund","year":"2018","unstructured":"Lund E, Nakamura A, Thalabard JC. No overdiagnosis in the Norwegian Breast Cancer Screening Program estimated by combining record linkage and questionnaire information in the Norwegian Women and Cancer study. Eur J Cancer. 2018Jan;89:102\u201312.","journal-title":"Eur J Cancer"},{"key":"2700_CR78","volume":"348","author":"H Weedon-Fekjaer","year":"2014","unstructured":"Weedon-Fekjaer H, Romundstad PR, Vatten LJ. Modern mammography screening and breast cancer mortality: population study. BMJ (Clinical research ed). 2014;348: g3701.","journal-title":"BMJ (Clinical research ed)"},{"issue":"9","key":"2700_CR79","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.7326\/M23-0133","volume":"176","author":"IB Richman","year":"2023","unstructured":"Richman IB, Long JB, Soulos PR, Wang SY, Gross CP. Estimating breast cancer overdiagnosis after screening mammography among older women in the United States. Ann Intern Med. 2023Sep 19;176(9):1172\u201380.","journal-title":"Ann Intern Med"},{"issue":"6","key":"2700_CR80","doi-asserted-by":"publisher","first-page":"381","DOI":"10.7326\/M18-1199","volume":"172","author":"X Garcia-Albeniz","year":"2020","unstructured":"Garcia-Albeniz X, Hernan MA, Logan RW, Price M, Armstrong K, Hsu J. Continuation of annual screening mammography and breast cancer mortality in women older than 70 years. Ann Intern Med. 2020;172(6):381\u20139.","journal-title":"Ann Intern Med"},{"issue":"2","key":"2700_CR81","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1002\/cam4.5004","volume":"12","author":"O Blyuss","year":"2023","unstructured":"Blyuss O, Dibden A, Massat NJ, Parmar D, Cuzick J, Duffy SW, et al. A case-control study to evaluate the impact of the breast screening programme on breast cancer incidence in England. Cancer Med. 2023;12(2):1878\u201387.","journal-title":"Cancer Med"},{"key":"2700_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2022.102320","volume":"82","author":"K De Troeyer","year":"2023","unstructured":"De Troeyer K, Silversmit G, Rosskamp M, Truyen I, Van Herck K, Goossens MM, et al. The effect of the Flemish breast cancer screening program on breast cancer-specific mortality: a case-referent study. Cancer Epidemiol. 2023;82: 102320.","journal-title":"Cancer Epidemiol"},{"issue":"4","key":"2700_CR83","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/s41416-020-01163-2","volume":"124","author":"R Maroni","year":"2021","unstructured":"Maroni R, Massat NJ, Parmar D, Dibden A, Cuzick J, Sasieni PD, et al. A case-control study to evaluate the impact of the breast screening programme on mortality in England. Br J Cancer. 2021Feb 16;124(4):736\u201343.","journal-title":"Br J Cancer"},{"key":"2700_CR84","doi-asserted-by":"crossref","unstructured":"Massat NJ, Dibden A, Parmar D, Cuzick J, Sasieni PD, Duffy SW. Impact of screening on breast cancer mortality: the UK program 20 Years On. 2016;25(3).","DOI":"10.1158\/1055-9965.EPI-15-0803"},{"issue":"2","key":"2700_CR85","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10552-014-0503-2","volume":"26","author":"G Pocobelli","year":"2015","unstructured":"Pocobelli G, Weiss NS. Breast cancer mortality in relation to receipt of screening mammography: a case\u2013control study in Saskatchewan. Canada Cancer Causes Control. 2015Feb;26(2):231\u20137.","journal-title":"Canada Cancer Causes Control"},{"key":"2700_CR86","doi-asserted-by":"crossref","unstructured":"Paap E, Verbeek ALM, Botterweck AAM, van Doorne-Nagtegaal HJ, Imhof-Tas M, e Koning HJ, et al. Breast cancer screening halves the risk of breast cancer death: a case-referent study. Breast (Edinburgh, Scotland). 2014;23(4):439\u201344.","DOI":"10.1016\/j.breast.2014.03.002"},{"issue":"31","key":"2700_CR87","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004335","volume":"95","author":"TM Ripping","year":"2016","unstructured":"Ripping TM, van der Waal D, Verbeek ALM, Broeders MJM. The relative effect of mammographic screening on breast cancer mortality by socioeconomic status. Medicine. 2016Aug;95(31): e4335.","journal-title":"Medicine"},{"key":"2700_CR88","doi-asserted-by":"crossref","unstructured":"Beckmann KR, Lynch JW, Hiller JE, Farshid G, Houssami N, Duffy SW, et al. A novel case-control design to estimate the extent of over-diagnosis of breast cancer due to organised population-based mammography screening. 2015;136(6).","DOI":"10.1002\/ijc.29124"},{"key":"2700_CR89","doi-asserted-by":"crossref","unstructured":"de Glas NA, e Craen AJM, Bastiaannet E, Op \u2019t Land EG, Kiderlen M, van de Water W, et al. Effect of implementation of the mass breast cancer screening programme in older women in the Netherlands: population based study. BMJ (Clinical research ed). 2014;349:g5410.","DOI":"10.1136\/bmj.g5410"},{"issue":"5","key":"2700_CR90","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/bjc.2014.642","volume":"112","author":"I Parvinen","year":"2015","unstructured":"Parvinen I, Hein\u00e4vaara S, Anttila A, Helenius H, Klemi P, Pylkk\u00e4nen L. Mammography screening in three Finnish residential areas: comprehensive population-based study of breast cancer incidence and incidence-based mortality 1976\u20132009. Br J Cancer. 2015;112(5):918\u201324.","journal-title":"Br J Cancer"},{"issue":"4","key":"2700_CR91","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/cncr.31840","volume":"125","author":"L Tab\u00e1r","year":"2019","unstructured":"Tab\u00e1r L, Dean PB, Chen TH, Yen AM, Chen SL, Fann JC, et al. The incidence of fatal breast cancer measures the increased effectiveness of therapy in women participating in mammography screening. Cancer. 2019Feb 15;125(4):515\u201323.","journal-title":"Cancer"},{"issue":"06","key":"2700_CR92","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1055\/a-1160-5569","volume":"80","author":"J H\u00fcbner","year":"2020","unstructured":"H\u00fcbner J, Katalinic A, Waldmann A, Kraywinkel K. Long-term incidence and mortality trends for breast cancer in Germany. Geburtshilfe Frauenheilkd. 2020Jun;80(06):611\u20138.","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"17","key":"2700_CR93","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/cncr.28784","volume":"120","author":"MA Helvie","year":"2014","unstructured":"Helvie MA, Chang JT, Hendrick RE, Banerjee M. Reduction in late-stage breast cancer incidence in the mammography era: Implications for overdiagnosis of invasive cancer. Cancer. 2014Sep;120(17):2649\u201356.","journal-title":"Cancer"},{"issue":"29","key":"2700_CR94","doi-asserted-by":"publisher","first-page":"4669","DOI":"10.1200\/JCO.23.00348","volume":"41","author":"AN Wilkinson","year":"2023","unstructured":"Wilkinson AN, Ellison LF, Billette JM, Seely JM. Impact of breast cancer screening on 10-year net survival in Canadian women Age 40\u201349 Years. J Clin Oncol. 2023Oct 10;41(29):4669\u201377.","journal-title":"J Clin Oncol"},{"issue":"8","key":"2700_CR95","doi-asserted-by":"publisher","first-page":"5627","DOI":"10.3390\/curroncol29080444","volume":"29","author":"AN Wilkinson","year":"2022","unstructured":"Wilkinson AN, Billette JM, Ellison LF, Killip MA, Islam N, Seely JM. The impact of organised screening programs on breast cancer stage at diagnosis for Canadian women aged 40\u201349 and 50\u201359. Curr Oncol. 2022;29(8):5627\u201343.","journal-title":"Curr Oncol"},{"key":"2700_CR96","doi-asserted-by":"crossref","unstructured":"Nystrom L, Bjurstam N, Jonsson H, Zackrisson S, Frisell J. Reduced breast cancer mortality after 20+ years of follow-up in the Swedish randomized controlled mammography trials in Malmo, Stockholm, and Goteborg. 2016;","DOI":"10.1177\/0969141316648987"},{"issue":"3","key":"2700_CR97","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1148\/radiol.11110469","volume":"260","author":"L Tab\u00e1r","year":"2011","unstructured":"Tab\u00e1r L, Vitak B, Chen THH, Yen AMF, Cohen A, Tot T, et al. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology. 2011Sep;260(3):658\u201363.","journal-title":"Radiology"},{"issue":"23","key":"2700_CR98","doi-asserted-by":"publisher","first-page":"5728","DOI":"10.1002\/cncr.27580","volume":"118","author":"AM Yen","year":"2012","unstructured":"Yen AM, Duffy SW, Chen TH, Chen L, Chiu SY, Fann JC, et al. Long-term incidence of breast cancer by trial arm in one county of the Swedish Two-County Trial of mammographic screening. Cancer. 2012Dec;118(23):5728\u201332.","journal-title":"Cancer"},{"key":"2700_CR99","doi-asserted-by":"crossref","unstructured":"Tabar L, Chen THH, Hsu CY, Wu WYY, Yen AMF, Chen SLS, et al. Evaluation issues in the Swedish Two-County Trial of breast cancer screening: An historical review. 2016;","DOI":"10.1177\/0969141316631375"},{"key":"2700_CR100","doi-asserted-by":"crossref","unstructured":"Baines CJ, To T, Miller AB. Revised estimates of overdiagnosis from the Canadian National Breast Screening Study. 2016;90.","DOI":"10.1016\/j.ypmed.2016.06.033"},{"issue":"10","key":"2700_CR101","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1002\/cncr.11361","volume":"97","author":"N Bjurstam","year":"2003","unstructured":"Bjurstam N, Bj\u00f6rneld L, Warwick J, Sala E, Duffy SW, Nystr\u00f6m L, et al. The Gothenburg breast screening trial: the Gothenburg breast screening trial. Cancer. 2003May 15;97(10):2387\u201396.","journal-title":"Cancer"},{"key":"2700_CR102","doi-asserted-by":"crossref","unstructured":"Moss SM, Wale C, Smith R, Evans A, Cuckle H, Duffy SW. Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years\u2019 follow-up: a randomised controlled trial. 2015;16(9).","DOI":"10.1016\/S1470-2045(15)00128-X"},{"key":"2700_CR103","unstructured":"Shapiro S. Current results of the breast cancer screening randomized trial. The Health Insurance Plan (HIP) of Greater New York Study. Screening for breast cancer. 1988;3\u201315."},{"issue":"7543","key":"2700_CR104","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1136\/bmj.38764.572569.7C","volume":"332","author":"S Zackrisson","year":"2006","unstructured":"Zackrisson S, Andersson I, Janzon L, Manjer J, Garne JP. Rate of over-diagnosis of breast cancer 15 years after end of Malm\u00f6 mammographic screening trial: follow-up study. BMJ. 2006;332(7543):689\u201392.","journal-title":"BMJ"},{"issue":"2","key":"2700_CR105","first-page":"317","volume":"77","author":"JDF Habbema","year":"1986","unstructured":"Habbema JDF, van Oortmarssen GJ, van Putten DJ, Lubbe JT, van der Maas PJ. Age-specific reduction in breast cancer mortality by screening: an analysis of the results of the Health Insurance Plan of Greater New York study. J Natl Cancer Inst. 1986;77(2):317\u201320.","journal-title":"J Natl Cancer Inst"},{"key":"2700_CR106","unstructured":"Shapiro S, Venet W, Strax P. Current results of the breast cancer screening randomized trial: the health insurance plan (HIP) of greater New York study. Hans Huber. 1988;3\u201315."},{"key":"2700_CR107","unstructured":"Habbema J, Oortmarssen G, Putten D van, Lubbe J, Maas P. Age-specific reduction in breast cancer mortality by screening: an analysis of the results of the Health Insurance Plan of Greater New York study. JNCI: Journal of the National Cancer Institute. 1986;77(2):317\u201320."},{"issue":"9310","key":"2700_CR108","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/S0140-6736(02)08020-0","volume":"359","author":"L Nystr\u00f6m","year":"2002","unstructured":"Nystr\u00f6m L, Andersson I, Bjurstam N, Frisell J, Nordenskj\u00f6ld B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. The Lancet. 2002Mar;359(9310):909\u201319.","journal-title":"The Lancet"},{"issue":"10","key":"2700_CR109","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1002\/1097-0142(19950515)75:10<2507::AID-CNCR2820751017>3.0.CO;2-H","volume":"75","author":"L Tabar","year":"1995","unstructured":"Tabar L, Fagerberg G, Chen H, Duffy S, Smart C, Gad A. Efficacy of breast cancer screening by age. Cancer. 1995;75(10):2507\u201317.","journal-title":"Cancer"},{"issue":"9","key":"2700_CR110","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/S1470-2045(15)00128-X","volume":"16","author":"SM Moss","year":"2015","unstructured":"Moss SM, Wale C, Smith R, Evans A, Cuckle H, Duffy SW. Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years\u2019 follow-up: a randomised controlled trial. Lancet Oncol. 2015;16(9):1123\u201332.","journal-title":"Lancet Oncol"},{"issue":"6","key":"2700_CR111","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1002\/ijc.29124","volume":"136","author":"KR Beckmann","year":"2015","unstructured":"Beckmann KR, Lynch JW, Hiller JE, Farshid G, Houssami N, Duffy SW, et al. A novel case-control design to estimate the extent of over-diagnosis of breast cancer due to organised population-based mammography screening. Int J Cancer. 2015;136(6):1411\u201321.","journal-title":"Int J Cancer"},{"issue":"3","key":"2700_CR112","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/ijc.32767","volume":"147","author":"A Katalinic","year":"2020","unstructured":"Katalinic A, Eisemann N, Kraywinkel K, Noftz MR, H\u00fcbner J. Breast cancer incidence and mortality before and after implementation of the German mammography screening program. Intl Journal of Cancer. 2020Aug;147(3):709\u201318.","journal-title":"Intl Journal of Cancer"},{"issue":"17","key":"2700_CR113","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/cncr.28784","volume":"120","author":"MA Helvie","year":"2014","unstructured":"Helvie MA, Chang JT, Hendrick RE, Banerjee M. Reduction in late-stage breast cancer incidence in the mammography era: Implications for overdiagnosis of invasive cancer. Cancer. 2014;120(17):2649\u201356.","journal-title":"Cancer"},{"issue":"3","key":"2700_CR114","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/S0749-3797(98)00074-9","volume":"15","author":"V Goel","year":"1998","unstructured":"Goel V, Cohen MM, Kaufert P, MacWilliam L. Assessing the extent of contamination in the Canadian National Breast Screening Study. Am J Prev Med. 1998Oct;15(3):206\u201311.","journal-title":"Am J Prev Med"},{"issue":"9","key":"2700_CR115","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/0895-4356(96)00117-5","volume":"49","author":"MM Cohen","year":"1996","unstructured":"Cohen MM, Kaufert PA, Macwilliam L, Tate RB. Using an alternative data source to examine randomization in the Canadian National Breast Screening Study. J Clin Epidemiol. 1996Sep;49(9):1039\u201344.","journal-title":"J Clin Epidemiol"},{"key":"2700_CR116","unstructured":"Bailar JC, MacMahon B. Randomization in the Canadian National Breast Screening Study: a review for evidence of subversion. CAN MED ASSOC J."},{"key":"2700_CR117","doi-asserted-by":"crossref","unstructured":"Baines CJ. The Canadian National Breast Screening Study. Why? What next? And so what? Cancer. 1995 Nov 15;76(10 Suppl):2107\u201312.","DOI":"10.1002\/1097-0142(19951115)76:10+<2107::AID-CNCR2820761333>3.0.CO;2-E"},{"key":"2700_CR118","unstructured":"Sterne, Hern\u00e1n, McAleenan, Reeves, Higgins. Chapter 25: Assessing risk of bias in a non-randomized study. In: Cochrane Handbook for Systematic Reviews of Interventions version 64 [Internet]. Cochrane; 2023. Available from: www.training.cochrane.org\/handbook."},{"issue":"1","key":"2700_CR119","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1093\/ije\/15.1.36","volume":"15","author":"JL Aron","year":"1986","unstructured":"Aron JL, Prorok PC. An analysis of the mortality effect in a breast cancer screening study. Int J Epidemiol. 1986;15(1):36\u201343.","journal-title":"Int J Epidemiol"},{"issue":"3","key":"2700_CR120","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1023\/A:1005872617944","volume":"45","author":"J Frisell","year":"1997","unstructured":"Frisell J, Lidbrink E, Hellstr\u00f6m L, Rutqvist LE. Followup after 11 years\u2014update of mortality results in the Stockholm mammographic screening trial. Breast Cancer Res Treat. 1997Sep;45(3):263\u201370.","journal-title":"Breast Cancer Res Treat"},{"key":"2700_CR121","doi-asserted-by":"crossref","unstructured":"Bjurstam NG, Bjorneld LM, Duffy SW. Updated results of the Gothenburg Trial of Mammographic Screening. 2016;122(12).","DOI":"10.1002\/cncr.29975"},{"key":"2700_CR122","doi-asserted-by":"publisher","unstructured":"G\u00f8tzsche PC, J\u00f8rgensen KJ. Screening for breast cancer with mammography. Cochrane database of systematic reviews [Internet]. 2013 [cited 2024 Feb 21];(6). Available from: https:\/\/www.cochranelibrary.com\/cdsr\/doi\/https:\/\/doi.org\/10.1002\/14651858.CD001877.pub5\/abstract","DOI":"10.1002\/14651858.CD001877.pub5\/abstract"},{"key":"2700_CR123","volume-title":"Breast cancer screening in Canada: monitoring and evaluation of quality indicators\u2014results report, January 2011 to December 2012","author":"CPA Cancer","year":"2016","unstructured":"Cancer CPA. Breast cancer screening in Canada: monitoring and evaluation of quality indicators\u2014results report, January 2011 to December 2012. Toronto: Canadian Partnership Against Cancer; 2016."},{"key":"2700_CR124","first-page":"084653712412464","volume":"25","author":"JM Seely","year":"2024","unstructured":"Seely JM, Ellison LF, Billette JM, Zhang SX, Wilkinson AN. Incidence of breast cancer in younger women: a Canadian trend analysis. Can Assoc Radiol J. 2024Apr;25:08465371241246422.","journal-title":"Can Assoc Radiol J"},{"key":"2700_CR125","unstructured":"Canadian Cancer Statistics Advisory Committee in collaboration with the Canadian Cancer Society, Statistics Canada and the Public Health Agency of Canada. Canadian Cancer Statistics 2023 [Internet]. 2023 [cited 2023 Nov 19]. Available from: cancer.ca\/Canadian-Cancer-Statistics-2023-EN"},{"issue":"3","key":"2700_CR126","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1001\/jama.2023.25881","volume":"331","author":"JL Caswell-Jin","year":"2024","unstructured":"Caswell-Jin JL, Sun LP, Munoz D, Lu Y, Li Y, Huang H, et al. Analysis of breast cancer mortality in the US\u20141975 to 2019. JAMA. 2024;331(3):233\u201341.","journal-title":"JAMA"},{"issue":"1","key":"2700_CR127","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12885-018-5201-0","volume":"19","author":"AK Lofters","year":"2019","unstructured":"Lofters AK, McBride ML, Li D, Whitehead M, Moineddin R, Jiang L, et al. Disparities in breast cancer diagnosis for immigrant women in Ontario and BC: results from the CanIMPACT study. BMC Cancer. 2019Jan 9;19(1):42.","journal-title":"BMC Cancer"},{"key":"2700_CR128","doi-asserted-by":"crossref","unstructured":"Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010 Jun 1;152(11):726\u201332.","DOI":"10.7326\/0003-4819-152-11-201006010-00232"},{"issue":"8","key":"2700_CR129","doi-asserted-by":"publisher","first-page":"663","DOI":"10.7326\/0003-4819-134-8-200104170-00012","volume":"134","author":"DG Altman","year":"2001","unstructured":"Altman DG. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med. 2001Apr 17;134(8):663.","journal-title":"Ann Intern Med"},{"issue":"14","key":"2700_CR130","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1200\/JCO.18.01074","volume":"37","author":"PD Soni","year":"2019","unstructured":"Soni PD, Hartman HE, Dess RT, Abugharib A, Allen SG, Feng FY, et al. Comparison of population-based observational studies with randomized trials in oncology. JCO. 2019May 10;37(14):1209\u201316.","journal-title":"JCO"},{"issue":"3","key":"2700_CR131","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s10549-023-06934-y","volume":"199","author":"T Ma","year":"2023","unstructured":"Ma T, Semsarian CR, Barratt A, Parker L, Pathmanathan N, Nickel B, et al. Should low-risk DCIS lose the cancer label? An evidence review. Breast Cancer Res Treat. 2023Jun;199(3):415\u201333.","journal-title":"Breast Cancer Res Treat"},{"key":"2700_CR132","doi-asserted-by":"crossref","unstructured":"Perou CM, S\u00f8rlie T, Eisen MB, Van De Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. nature. 2000;406(6797):747\u201352.","DOI":"10.1038\/35021093"},{"issue":"2","key":"2700_CR133","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1001\/jama.2017.19130","volume":"319","author":"SK Plevritis","year":"2018","unstructured":"Plevritis SK, Munoz D, Kurian AW, Stout NK, Alagoz O, Near AM, et al. Association of screening and treatment with breast cancer mortality by molecular subtype in US women, 2000\u20132012. JAMA. 2018;319(2):154\u201364.","journal-title":"JAMA"},{"issue":"4","key":"2700_CR134","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1177\/0969141318780152","volume":"25","author":"MJ Yaffe","year":"2018","unstructured":"Yaffe MJ, Mittmann N, Alagoz O, Trentham-Dietz A, Tosteson AN, Stout NK. The effect of mammography screening regimen on incidence-based breast cancer mortality. J Med Screen. 2018Dec;25(4):197\u2013204.","journal-title":"J Med Screen"},{"issue":"15","key":"2700_CR135","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1001\/jama.2015.12783","volume":"314","author":"KC Oeffinger","year":"2015","unstructured":"Oeffinger KC, Fontham ET, Etzioni R, Herzig A, Michaelson JS, Shih YCT, et al. Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA. 2015;314(15):1599\u2013614.","journal-title":"JAMA"},{"key":"2700_CR136","unstructured":"Government of Canada SC. Deaths and age-specific mortality rates, by selected grouped causes [Internet]. 2021 [cited 2024 Feb 29]. Available from: https:\/\/www150.statcan.gc.ca\/t1\/tbl1\/en\/tv.action?pid=1310039201"},{"key":"2700_CR137","doi-asserted-by":"crossref","unstructured":"Yaffe MJ, Mainprize JG. The value of all-cause mortality as a metric for assessing breast cancer screening. JNCI: Journal of the National Cancer Institute. 2020;112(10):989\u201393.","DOI":"10.1093\/jnci\/djaa025"},{"issue":"13","key":"2700_CR138","doi-asserted-by":"publisher","first-page":"6127","DOI":"10.1002\/cam4.2476","volume":"8","author":"EAM Heijnsdijk","year":"2019","unstructured":"Heijnsdijk EAM, Csan\u00e1di M, Gini A, Ten Haaf K, Bendes R, Anttila A, et al. All-cause mortality versus cancer-specific mortality as outcome in cancer screening trials: a review and modeling study. Cancer Med. 2019Oct;8(13):6127\u201338.","journal-title":"Cancer Med"},{"issue":"9","key":"2700_CR139","doi-asserted-by":"publisher","first-page":"7860","DOI":"10.3390\/curroncol30090571","volume":"30","author":"AN Wilkinson","year":"2023","unstructured":"Wilkinson AN, Seely JM, Rushton M, Williams P, Cordeiro E, Allard-Coutu A, et al. Capturing the true cost of breast cancer treatment: molecular subtype and stage-specific per-case activity-based costing. Curr Oncol. 2023;30(9):7860\u201373.","journal-title":"Curr Oncol"},{"issue":"1","key":"2700_CR140","doi-asserted-by":"publisher","first-page":"324","DOI":"10.2214\/ajr.184.1.01840324","volume":"184","author":"RJ Barth","year":"2005","unstructured":"Barth RJ, Gibson GR, Carney PA, Mott LA, Becher RD, Poplack SP. Detection of breast cancer on screening mammography allows patients to be treated with less-toxic therapy. Am J Roentgenol. 2005Jan;184(1):324\u20139.","journal-title":"Am J Roentgenol"},{"issue":"10","key":"2700_CR141","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1245\/s10434-018-6646-8","volume":"25","author":"S Ahn","year":"2018","unstructured":"Ahn S, Wooster M, Valente C, Moshier E, Meng R, Pisapati K, et al. Impact of screening mammography on treatment in women diagnosed with breast cancer. Ann Surg Oncol. 2018Oct;25(10):2979\u201386.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"2700_CR142","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.2214\/ajr.184.5.01841508","volume":"184","author":"JWT Leung","year":"2005","unstructured":"Leung JWT. Screening mammography reduces morbidity of breast cancer treatment. Am J Roentgenol. 2005May;184(5):1508\u20139.","journal-title":"Am J Roentgenol"},{"issue":"9","key":"2700_CR143","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1245\/s10434-018-6469-7","volume":"25","author":"K Elder","year":"2018","unstructured":"Elder K, Nickson C, Pattanasri M, Cooke S, Machalek D, Rose A, et al. Treatment intensity differences after early-stage breast cancer (ESBC) diagnosis depending on participation in a screening program. Ann Surg Oncol. 2018Sep;25(9):2563\u201372.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"2700_CR144","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1002\/cncr.11605","volume":"98","author":"GM Freedman","year":"2003","unstructured":"Freedman GM, Anderson PR, Goldstein LJ, Hanlon AL, Cianfrocca ME, Millenson MM, et al. Routine mammography is associated with earlier stage disease and greater eligibility for breast conservation in breast carcinoma patients age 40 years and older. Cancer. 2003Sep;98(5):918\u201325.","journal-title":"Cancer"},{"issue":"10","key":"2700_CR145","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1002\/ijc.22545","volume":"120","author":"AJ Coldman","year":"2007","unstructured":"Coldman AJ, Phillips N, Speers C. A retrospective study of the effect of participation in screening mammography on the use of chemotherapy and breast conserving surgery. Intl Journal of Cancer. 2007May 15;120(10):2185\u201390.","journal-title":"Intl Journal of Cancer"},{"issue":"2","key":"2700_CR146","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1804710","volume":"379","author":"JA Sparano","year":"2018","unstructured":"Sparano JA, Gray RJ, Makower DF, Pritchard KI, Albain KS, Hayes DF, et al. Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer. N Engl J Med. 2018Jul 12;379(2):111\u201321.","journal-title":"N Engl J Med"},{"issue":"7","key":"2700_CR147","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1056\/NEJMoa2302344","volume":"389","author":"TJ Whelan","year":"2023","unstructured":"Whelan TJ, Smith S, Parpia S, Fyles AW, Bane A, Liu FF, et al. Omitting radiotherapy after breast-conserving surgery in luminal a breast cancer. N Engl J Med. 2023Aug 17;389(7):612\u20139.","journal-title":"N Engl J Med"},{"issue":"11","key":"2700_CR148","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1056\/NEJM198503143121101","volume":"312","author":"B Fisher","year":"1985","unstructured":"Fisher B, Bauer M, Margolese R, Poisson R, Pilch Y, Redmond C, et al. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med. 1985Mar 14;312(11):665\u201373.","journal-title":"N Engl J Med"},{"issue":"12","key":"2700_CR149","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1007\/s11606-014-2878-x","volume":"29","author":"TW Concannon","year":"2014","unstructured":"Concannon TW, Fuster M, Saunders T, Patel K, Wong JB, Leslie LK, et al. A systematic review of stakeholder engagement in comparative effectiveness and patient-centered outcomes research. J GEN INTERN MED. 2014Dec 1;29(12):1692\u2013701.","journal-title":"J GEN INTERN MED"},{"issue":"5","key":"2700_CR150","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/j.1369-7625.2012.00795.x","volume":"17","author":"J Brett","year":"2014","unstructured":"Brett J, Staniszewska S, Mockford C, Herron-Marx S, Hughes J, Tysall C, et al. Mapping the impact of patient and public involvement on health and social care research: a systematic review. Health Expect. 2014;17(5):637\u201350.","journal-title":"Health Expect"},{"issue":"3","key":"2700_CR151","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1377\/hlthaff.2018.05067","volume":"38","author":"LP Forsythe","year":"2019","unstructured":"Forsythe LP, Carman KL, Szydlowski V, Fayish L, Davidson L, Hickam DH, et al. Patient engagement in research: early findings from the patient-centered outcomes research institute. Health Aff. 2019Mar;38(3):359\u201367.","journal-title":"Health Aff"},{"issue":"2","key":"2700_CR152","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1148\/radiol.2016161444","volume":"283","author":"CK Kuhl","year":"2017","unstructured":"Kuhl CK, Strobel K, Bieling H, Leutner C, Schild HH, Schrading S. Supplemental breast MR imaging screening of women with average risk of breast cancer. Radiology. 2017May 1;283(2):361\u201370.","journal-title":"Radiology"},{"issue":"22","key":"2700_CR153","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1056\/NEJMoa1903986","volume":"381","author":"MF Bakker","year":"2019","unstructured":"Bakker MF, De Lange SV, Pijnappel RM, Mann RM, Peeters PHM, Monninkhof EM, et al. Supplemental MRI screening for women with extremely dense breast tissue. N Engl J Med. 2019Nov 28;381(22):2091\u2013102.","journal-title":"N Engl J Med"},{"issue":"2","key":"2700_CR154","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1148\/radiol.2021203633","volume":"299","author":"SGA Veenhuizen","year":"2021","unstructured":"Veenhuizen SGA, De Lange SV, Bakker MF, Pijnappel RM, Mann RM, Monninkhof EM, et al. Supplemental breast MRI for women with extremely dense breasts: results of the second screening round of the DENSE trial. Radiology. 2021May;299(2):278\u201386.","journal-title":"Radiology"},{"key":"2700_CR155","doi-asserted-by":"crossref","unstructured":"Ohuchi N, Suzuki A, Sobue T, Kawai M, Yamamoto S, Zheng YF, et al. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. 2016;387(10016).","DOI":"10.1016\/S0140-6736(15)00774-6"},{"issue":"10","key":"2700_CR156","doi-asserted-by":"publisher","first-page":"673","DOI":"10.7326\/M14-1465","volume":"162","author":"K Kerlikowske","year":"2015","unstructured":"Kerlikowske K, Zhu W, Tosteson ANA, Sprague BL, Tice JA, Lehman CD, et al. Identifying women with dense breasts at high risk for interval cancer: a cohort study. Ann Intern Med. 2015May 19;162(10):673\u201381.","journal-title":"Ann Intern Med"},{"key":"2700_CR157","doi-asserted-by":"crossref","unstructured":"Poelhekken K, Lin Y, Greuter MJ, van der Vegt B, Dorrius M, de Bock GH. The natural history of ductal carcinoma in situ (DCIS) in simulation models: a systematic review. The Breast [Internet]. 2023 [cited 2024 Feb 29]; Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0960977623005350","DOI":"10.1016\/j.breast.2023.07.012"},{"issue":"1","key":"2700_CR158","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13058-016-0705-5","volume":"18","author":"PA Van Luijt","year":"2016","unstructured":"Van Luijt PA, Heijnsdijk EAM, Fracheboud J, Overbeek LIH, Broeders MJM, Wesseling J, et al. The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening. Breast Cancer Res. 2016Dec;18(1):47.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"2700_CR159","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13058-020-01287-6","volume":"22","author":"S Chootipongchaivat","year":"2020","unstructured":"Chootipongchaivat S, Van Ravesteyn NT, Li X, Huang H, Weedon-Fekj\u00e6r H, Ryser MD, et al. Modeling the natural history of ductal carcinoma in situ based on population data. Breast Cancer Res. 2020Dec;22(1):53.","journal-title":"Breast Cancer Res"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-024-02700-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13643-024-02700-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-024-02700-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T04:10:38Z","timestamp":1734581438000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-024-02700-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,19]]},"references-count":159,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2700"],"URL":"https:\/\/doi.org\/10.1186\/s13643-024-02700-3","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,19]]},"assertion":[{"value":"30 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors provided consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Anna Wilkinson is a consultant for Thrive Health, Survivor Advisor and has received honoraria from Cancer Care Ontario\/The Ottawa Hospital: Regional Cancer Primary Care Lead. Dr. David Moher was previously Co-Editor-in-Chief with <i>Systematic Reviews<\/i>.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"304"}}